Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Tropisetron hydrochloride in Nausea: NCT07413809 Clinical Landscape Report 2026
9 min read
Tropisetron hydrochloride in Nausea: NCT07413809 Clinical Landscape Report 2026
28 September 2026
NCT07413809 clinical landscape for Nausea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Gamgertamig in Refractory Multiple Myeloma: NCT07407010 Clinical Landscape Report 2026
9 min read
Gamgertamig in Refractory Multiple Myeloma: NCT07407010 Clinical Landscape Report 2026
28 September 2026
NCT07407010 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
TQH-3906 in Arthritis, Psoriatic: NCT07406035 Clinical Landscape Report 2026
9 min read
TQH-3906 in Arthritis, Psoriatic: NCT07406035 Clinical Landscape Report 2026
28 September 2026
NCT07406035 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Gamgertamig in Multiple Myeloma: NCT07409454 Clinical Landscape Report 2026
9 min read
Gamgertamig in Multiple Myeloma: NCT07409454 Clinical Landscape Report 2026
28 September 2026
NCT07409454 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
ABBV-438 in Relapse multiple myeloma: NCT07409246 Clinical Landscape Report 2026
9 min read
ABBV-438 in Relapse multiple myeloma: NCT07409246 Clinical Landscape Report 2026
28 September 2026
NCT07409246 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SENL-103 in Relapse multiple myeloma: NCT07421856 Clinical Landscape Report 2026
9 min read
SENL-103 in Relapse multiple myeloma: NCT07421856 Clinical Landscape Report 2026
28 September 2026
NCT07421856 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ziftomenib in IDH1 Mutation Acute Myeloid Leukemia: NCT07411586 Clinical Landscape Report 2026
9 min read
Ziftomenib in IDH1 Mutation Acute Myeloid Leukemia: NCT07411586 Clinical Landscape Report 2026
28 September 2026
NCT07411586 clinical landscape for IDH1 Mutation Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
Luteolin in Asteatotic eczema: TCTR20260220001 Clinical Landscape Report 2026
9 min read
Luteolin in Asteatotic eczema: TCTR20260220001 Clinical Landscape Report 2026
28 September 2026
TCTR20260220001 clinical landscape for Asteatotic eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Cladribine in Acute Myeloid Leukemia: NCT07423104 Clinical Landscape Report 2026
9 min read
Cladribine in Acute Myeloid Leukemia: NCT07423104 Clinical Landscape Report 2026
28 September 2026
NCT07423104 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
CNSI-Fe in Lung Cancer: NCT07433283 Clinical Landscape Report 2026
9 min read
CNSI-Fe in Lung Cancer: NCT07433283 Clinical Landscape Report 2026
28 September 2026
NCT07433283 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Zimberelimab in Squamous cell carcinoma of vulva: NCT07424664 Clinical Landscape Report 2026
9 min read
Zimberelimab in Squamous cell carcinoma of vulva: NCT07424664 Clinical Landscape Report 2026
28 September 2026
NCT07424664 clinical landscape for Squamous cell carcinoma of vulva: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Venetoclax in Adult Acute Myeloblastic Leukemia: NCT07425782 Clinical Landscape Report 2026
9 min read
Venetoclax in Adult Acute Myeloblastic Leukemia: NCT07425782 Clinical Landscape Report 2026
28 September 2026
NCT07425782 clinical landscape for Adult Acute Myeloblastic Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →